Outcome of lupus nephritis in childhood onset SLE in North and Central India: Single-centre experience over 25 years

Lupus

Volumn 25, Issue 5, 2016, Pages 547-557

  Srivastava, P ^a   Abujam, B ^a   Misra, R ^a   Lawrence, A ^a   Agarwal, V ^a   Aggarwal, Amita ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

childhood lupus nephritis; nephritis; renal lupus; Systemic lupus erythematosus

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; AZATHIOPRINE; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PREDNISONE; RITUXIMAB;

ADOLESCENT; ANTIMICROBIAL THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BACTERIAL INFECTION; CHILD; CHILDHOOD DISEASE; CHILDHOOD ONSET SYSTEMIC LUPUS ERYTHEMATOSUS; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DISEASE COURSE; DISEASE DURATION; DISEASE EXACERBATION; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INDIA; KIDNEY BIOPSY; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MORTALITY; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEINURIA; REMISSION; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SEPSIS; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TUBERCULOSIS; BIOPSY; CAUSE OF DEATH; CHI SQUARE DISTRIBUTION; COMMUNICABLE DISEASES; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; KIDNEY FAILURE, CHRONIC; LUPUS NEPHRITIS; MULTIVARIATE ANALYSIS; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME;

ADOLESCENT; AGE OF ONSET; ANTI-INFECTIVE AGENTS; BIOPSY; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; CHILD; COMMUNICABLE DISEASES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; INDIA; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; LUPUS NEPHRITIS; MALE; MULTIVARIATE ANALYSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84962585578     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203315619031     Document Type: Article

References (50)

1. Mina R, Brunner HI,. Pediatric lupus-are there differences in presentation, genetics, response to therapy, damage accrual compared to adult lupus? Rheum Dis Clin North Am 2010; 36: 53-80.
2. Aggarwal A, Srivastava P,. Childhood onset systemic lupus erythematosus: How is it different from adult SLE? Int J Rheum Dis 2015; 18: 182-191.
3. Weiss JE,. Pediatric systemic lupus erythematosus: More than a positive antinuclear antibody. Pediatr Rev 2012; 33: 62-73.
4. Vachvanichsanong P, McNeil E,. Pediatric lupus nephritis: More options, more chances? Lupus 2013; 22: 545-553.
5. Brunner HI, Huggins J, Klein-Gitelman MS,. Pediatric SLE-towards a comprehensive management plan. Nat Rev Rheumatol 2011; 7: 225-233.
6. Levy DM, Peschken CA, Tucker LB, et al. Influence of ethnicity on childhood-onset systemic lupus erythematosus: Results from a multiethnic multicenter Canadian cohort. Arthritis Care Res (Hoboken) 2013; 65: 152-160.
7. Petri M,. Lupus in Baltimore: Evidence-based 'clinical pearls' from the Hopkins Lupus Cohort. Lupus 2005; 14: 970-973.
8. Levy DM, Kamphuis S,. Systemic lupus erythematosus in children and adolescents. Pediatr Clin North Am 2012; 59: 345-364.
9. Hiraki LT, Benseler SM, Tyrrell PN, Harvey E, Hebert D, Silverman ED,. Ethnic differences in pediatric systemic lupus erythematosus. J Rheumatol 2009; 36: 2539-2546.
10. Tucker LB, Uribe AG, Fernandez M, et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: Results of a nested matched case-control study within LUMINA, a multi-ethnic US cohort (LUMINA LVII). Lupus 2008; 17: 314-322.
11. Singh S, Abujam B, Gupta A, et al. Childhood lupus nephritis in a developing country-24 years' single-center experience from North India. Lupus 2015; 24: 641-647.
12. Hari P, Bagga A, Mahajan P, Dinda A,. Outcome of lupus nephritis in Indian children. Lupus 2009; 18: 348-354.
13. Agarwal I, Kumar TS, Ranjini K, Kirubakaran C, Danda D,. Clinical features and outcome of systemic lupus erythematosus. Indian Pediatr 2009; 46: 711-715.
14. Dhir V, Aggarwal A, Lawrence A, Agarwal V, Misra R,. Long-term outcome of lupus nephritis in Asian Indians. Arthritis Care Res (Hoboken) 2012; 64: 7137-7120.
15. Nandi M, Mondal R,. Renal involvement in childhood lupus: A study from Kolkata, India. Saudi J Kidney Dis Transpl 2012; 23: 871-875.
16. Pradhan V, Patwardhan M, Rajadhyaksha A, Ghosh K,. Clinical and immunological profile of systemic lupus erythematosus. Indian Pediatr 2013; 50: 405-407.
17. Hahn BH, McMahon M, Wilkinson A, et al. American College of Rheumatology guidelines for screening, case definition, treatment and management of lupus nephritis. Arthritis Care Res 2012; 64: 797-808.
18. Bagga A, Mantan M,. Nephrotic syndrome in children. Indian J Med Res 2005; 122: 13-28.
19. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100.
20. Furqan M, Haque A,. Surface area in children: A simple formula. Indian Pediatr 2009; 46: 1085-1087.
21. Update on 1987 Task Force Report on High Blood Pressure in Children and Adolescents: A working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics 1996; 98 (4 Pt 1): 649-658.
22. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15: 241-250.
23. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH,. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
24. Sprangers B, Monahan M, Appel GB,. Diagnosis and treatment of lupus nephritis flares-an update. Nat Rev Nephrol 2012; 8: 709-717.
25. Gladman DD, Ginzler E, Goldsmith CH, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
26. Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria. The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum 2006; 54: 421-432.
27. Wong SN, Tse KC, Lee TL, et al. Lupus nephritis in Chinese children-a territory-wide cohort study in Hong Kong. Pediatr Nephrol 2006; 21: 1104-1112.
28. Lee PY, Yeh KW, Yao KW, et al. The outcome of patients with renal involvement in pediatric-onset systemic lupus erythematosus-a 20-year experience in Asia. Lupus 2013; 22: 1534-1540.
29. Ataei N, Haydarpour M, Madani A, et al. Outcome of lupus nephritis in Iranian children: Prognostic significance of certain features. Pediatr Nephrol 2008; 23: 749-755.
30. Bakr A,. Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt. Pediatr Nephrol 2005; 20: 1081-1086.
31. Ruggiero B, Vivarelli M, Gianviti A, et al. Lupus nephritis in children and adolescents: Results of the Italian Collaborative Study. Nephrol Dial Transplant 2013; 28: 1-8.
32. Pereira T, Abitbol CL, Seeherunvong W, et al. Three decades of progress in treating childhood-onset lupus nephritis. Clin J Am Soc Nephrol 2011; 6: 2192-2199.
33. Sun L, Xu H, Liu HM, et al. Long-term follow-up of 101 cases with pediatric lupus nephritis in a single center in Shanghai [article in Chinese]. Zhonghua Er Ke Za Zhi 2011; 49: 819-824.
34. Kopkinson ND, Jenkinson C, Muir KR, Doherty M, Powell RJ,. Racial group, socioeconomic status, and the development of persistent proteinuria in systemic lupus erythematosus. Ann Rheum Dis 2000; 59: 116-119.
35. Huang JL, Lin CJ, Hung IJ, Luo SF,. The morbidity and mortality associated with childhood onset systemic lupus erythematosus. Changgeng Yi Xue Za Zhi 1994; 17: 113-120.
36. Chen MJ, Tseng HM, Huang YL, et al. Long-term outcome and short-term survival of patients with systemic lupus erythematosus after bacteraemia episodes: 6-yr follow-up. Rheumatology (Oxford) 2008; 47: 1352-1357.
37. Steinberg AD, Steinberg SC,. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only. Arthritis Rheum 1991; 34: 945-950.
38. Chan TM, Li FK, Tang CS, et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med 2000; 343: 1156-1162.
39. Vachvanichsanong P, Dissaneewate P, McNeil E,. Twenty-two years' experience with childhood-onset SLE in a developing country: Are outcomes similar to developed countries? Arch Dis Child 2011; 96: 44-49.
40. Sidiropoulos PI, Kritikos HD, Boumpas DT,. Lupus nephritis flares. Lupus 2005; 14: 49-52.
41. Inês L, Duarte C, Silva RS, Teixeira AS, Fonseca FP, da Silva JA,. Identification of clinical predictors of flare in systemic lupus erythematosus patients: A 24-month prospective cohort study. Rheumatology (Oxford) 2014; 53: 85-89.
42. Gutiérrez-Suárez R, Ruperto N, Gastaldi R, et al. A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2989-2996.
43. Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM,. Risk factors for damage in childhood-onset systemic lupus erythematosus: Cumulative disease activity and medication use predict disease damage. Arthritis Rheum 2002; 46: 436-444.
44. Daleboudt GM, Bajema IM, Goemaere NN, van Laar JM, Bruijn JA, Berger SP,. The clinical relevance of a repeat biopsy in lupus nephritis flares. Nephrol Dial Transplant 2009; 24: 3712-3717.
45. Lu J, Tam LS, Lai FM, et al. Repeat renal biopsy in lupus nephritis: A change in histological pattern is common. Am J Nephrol 2011; 34: 220-225.
46. Moroni G, Pasquali S, Quaglini S, et al. Clinical and prognostic value of serial renal biopsies in lupus nephritis. Am J Kidney Dis 1999; 34: 530-539.
47. Lee PP, Lee TL, Ho MH, Wong WH, Lau YL,. Recurrent major infections in juvenile-onset systemic lupus erythematosus-a close link with long-term disease damage. Rheumatology (Oxford) 2007; 46: 1290-1296.
48. Chen YS, Yang YH, Lin YT, Chiang BL,. Risk of infection in hospitalized children with systemic lupus erythematosus: A 10-year follow-up. Clin Rheumatol 2004; 23: 235-238.
49. Vachvanichsanong P, Dissaneewate P, McNeil E,. Diffuse proliferative glomerulonephritis does not determine the worst outcome in childhood-onset lupus nephritis: A 23-year experience in a single centre. Nephrol Dial Transplant 2009; 24: 2729-2734.
50. Gibson KL, Gipson DS, Massengill SA, et al. Predictors of relapse and end stage kidney disease in proliferative lupus nephritis: Focus on children, adolescents, and young adults. Clin J Am Soc Nephrol 2009; 4: 1962-1967.